imodium and tirzepatide FDA approves tirzepatide, Eli Lilly's new type 2 diabetes drug, and the company shares an estimated price Can I restart tirzepatide (Zepbound)

Sato T, Azuma Y, Ozone C, Okazaki M, Takeda A, Okada M, Futamura K, Hiramitsu T, Goto N, Narumi S, et al

In clinical trials for Contrave, between 36% and 57% of people (depending on which study) lost 5% or more of body weight, and 15% to 35% of people lost 10% or more

Is retatrutide suitable for everyone with diabetes or obesity

In a deal announced Nov

The risk factors of NEC include premature delivery, no breastfeeding (151), increased antibiotic exposure (152), and intestinal microbial ecological imbalance (153)

Establishing a reliable routine is essential for maintaining consistent GLP-1 therapy and achieving optimal treatment outcomes